Schizophrenia is a serious psychiatric disorder that affects how people feel, think, and behave. It impacts approximately 1% of the population, or about 3.5 million people in the United States.
This condition is a major cause of disability and death, and it has a strong genetic component, with around 80% of the risk being inherited.
Researchers have long known that genetics play a big role in schizophrenia, but understanding the exact genes that contribute to the condition has been a major challe…
A new study, published in the journal Advanced Science, sheds light on this issue by identifying important new genetic clues that could improve our understanding of schizophrenia.
The research, led by Bingshan Li, a professor at the Department of Molecular Physiology and Biophysics, explores how small genetic changes, previously overlooked, may play a key role in the development of schizophrenia.
The paper is titled “Analyses of GWAS and Sub-Threshold Loci Lead to the Discovery of Dendrite Development and Morphology Dysfunction Underlying Schizophrenia Genetic Risk.”
One of the main challenges in schizophrenia research is identifying the genetic variants that contribute to the condition. While large genetic studies have linked over 200 loci—specific areas on chromosomes—to schizophrenia, scientists estimate that more than 1,000 genes may be involved in the disorder.
Most studies have focused on the strongest genetic signals, but this approach misses many smaller, yet still significant, genetic changes. In their study, the team used a novel method that looked not only at the stron…
This approach led to the discovery of a biological process that is disrupted in schizophrenia: the development and morphology of dendrites. Dendrites are the branches that extend from nerve cells, allowing them to communicate with each other.
They are essential for proper brain function, and disruptions in how they grow and form connections could lead to serious cognitive and behavioral issues. By looking at weaker genetic signals, the researchers identified that problems with dendritic morphogenesis—how d…
Rui Chen, one of the study’s lead authors, explained that the research sought to go beyond the standard method of focusing only on the strongest genetic signals.
“We took a different route by also looking at the many genetic signals that almost but don’t quite reach the usual threshold for discovery. By developing a rigorous way to integrate these sub-threshold signals with the traditional ones, we uncovered hidden patterns that would otherwise have remained invisible.”
To confirm these findings, the team used human induced pluripotent stem cells (iPSCs) to model how the identified genes affect dendritic growth. When they increased the expression of two key genes—DCC and CUL7—in the neurons, they observed that the dendrites became shorter and had fewer branches.
This directly linked the genetic risk for schizophrenia to changes in brain structure, providing new insights into how the disorder might develop.
The study’s findings open up new possibilities for understanding and treating schizophrenia. By identifying specific genetic pathways involved in dendrite growth, the research gives scientists a concrete set of targets for future drug development.
Instead of focusing solely on managing the chemical imbalances in the brain, this approach could lead to treatments that address the underlying physical changes in the brain that contribute to schizophrenia.
In the short term, the researchers hope that their findings will change how schizophrenia is understood. “We hope our results will help researchers and clinicians see schizophrenia in a new light—not just as a ‘chemical imbalance,’ but also as a disorder of how brain cells connect and communicate,” said Chen.
Looking forward, the team aims to build on their work by investigating other genetic signals that might contribute to schizophrenia. By using larger datasets and studying how these genetic changes affect brain development, they hope to identify new genes that could predict disease at earlier stages or help to intervene before the illness fully develops.
Ultimately, the long-term goal is to develop new treatments that go beyond symptom management. “We hope to guide the development of therapies that can protect or restore brain cell connections,” said Chen. This could lead to precision treatments based on a patient’s genetic profile, improving outcomes for those living with schizophrenia.
In conclusion, this groundbreaking research points to a new direction for schizophrenia research. By linking genetic risk to brain structural changes, it opens the door to new diagnostic tools and treatments that could change the way we approach this complex and challenging disorder.
If you care about mental health, please read studies about how dairy foods may influence depression risk, and 6 foods you can eat to improve mental health.
For more mental health information, please see recent studies about top foods to tame your stress, and Omega-3 fats may help reduce depression.
Copyright © 2025 Knowridge Science Report. All rights reserved.
